Human Immunoglobulin (Ph4) For Intravenous Injection

Products

Information

The main component of this preparation is human immunoglobulin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process contains a step to remove anticomplementary activity and a dual viral inactivation process. 【Indications】 1. Primary agammaglobulinemia, such as X-linked hypogammaglobulinemia, common variant immunodeficiency diseases, immunoglobulin G subclass deficiency, etc. 2. Secondary immunoglobulin deficiency diseases, such as severe infection, septicemia of newborn, etc 3. Autoimmune diseases, such as primary thrombocytopenic purpura, Kawasaki disease. 【Specifications】 0.5g/vial (5%, 10ml), 1 g/vial (5%, 20ml), 1.25g/vial (5%, 25ml), 2.5g/vial (5%, 50ml), 5gvial (5%, 100ml), 10g/vial (5%, 200ml).
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
China
All categories
Biopharmaceutical ProductsFinished Dosage FormsBiopharmaceuticals (general category)ImmunologyProducts
Main Categories
Biopharmaceutical ProductsFinished Dosage Forms

Log in

See all the content and easy-to-use features by logging in or registering!